GlassScriptPhysician profile
Damon Davis
NPI 1437275641
$12,228.00
in general payments reported to CMS, 2019-2025
42 companies · $4,192 in 2025
The $4,192 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $946 · 2020: $409 · 2021: $1,773 · 2022: $1,187 · 2023: $730 · 2024: $2,991 · 2025: $4,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,048 · Travel and Lodging: $2,990 · Consulting Fee: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,048.37 |
| Travel and Lodging | $2,989.73 |
| Consulting Fee | $875.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,094.38 | 2021-2024 | Axonics, Bulkamid |
| Profound Medical Corp. | $1,998.54 | 2025 | Tulsa-Pro |
| Boston Scientific Corporation | $1,221.46 | 2019-2025 | Axonics, Ams 700, Spaceoar Vue System - 10ml |
| Olympus Winter & Ibe Gmbh | $875.00 | 2025 | Endoeye Flex Deflectable Videoscope |
| Olympus America INC. | $467.58 | 2019-2025 | Itind System, Uropass |
| Astellas Pharma US INC | $395.45 | 2019-2024 | Xtandi, Myrbetriq |
| Coloplast Corp | $339.43 | 2019-2025 | Altis |
| Abbvie INC. | $310.50 | 2020-2025 | Botox |
| Procept Biorobotics Corporation | $271.49 | 2024 | Aquabeam System |
| Teleflex LLC | $167.96 | 2022-2024 | Urolift |
| Tolmar Pharmaceuticals, INC. | $164.39 | 2019-2022 | |
| Medtronic USA, INC. | $152.41 | 2019 | |
| Sumitomo Pharma America, INC. | $134.82 | 2023-2025 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $125.35 | 2022 | |
| Janssen Biotech, INC. | $120.27 | 2021-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $117.26 | 2023-2025 | Jelmyto |
| Renovia INC | $113.89 | 2020 | |
| Ferring Pharmaceuticals INC. | $102.99 | 2019-2025 | Adstiladrin |
| Baxter Healthcare | $100.51 | 2019-2025 | Tisseel |
| 180 Medical, INC. | $89.78 | 2020-2023 | Gentlecath |
| Philips North America LLC | $82.93 | 2023-2024 | (Dv6) Ei Sales Nam |
| Allergan, INC. | $80.43 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $75.10 | 2020-2025 | Keytruda |
| Ethicon US, LLC | $72.30 | 2022-2023 | Enseal |
| Tolmar, INC. | $63.32 | 2024-2025 | Eligard |
| Endo USA, INC. | $53.63 | 2024 | Xiaflex, Aveed |
| Photocure INC | $53.04 | 2021-2025 | Cysview |
| Antares Pharma, INC. | $45.41 | 2019-2020 | |
| Neotract INC. | $43.85 | 2019 | |
| Endo Pharmaceuticals INC. | $37.28 | 2020-2024 | Xiaflex, Aveed |
| Pfizer INC. | $27.80 | 2019 | |
| Angiodynamics, INC. | $26.32 | 2022 | |
| Valencia Technologies Corporation | $26.01 | 2025 | Ecoin Device Kit |
| Abc Home Medical Supply, INC. | $25.64 | 2025 | |
| Halozyme INC | $24.66 | 2023 | |
| Myovant Sciences INC. | $22.51 | 2022 | |
| Calyxo, INC. | $19.14 | 2025 | Cvac Aspiration System |
| Convatec INC. | $18.95 | 2021 | |
| Conmed Corporation | $17.84 | 2025 | Airseal |
| Metuchen Pharmaceuticals | $17.10 | 2019 | |
| Telix Pharmaceuticals | $16.75 | 2024 | Illuccix |
| Bayer Healthcare Pharmaceuticals INC. | $14.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damon Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.